Arcturus Therapeutics Holdings Inc. (ARCT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 13.98 |
| Open | 14.02 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1400 |
| Day's Range | 13.99 - 15.58 |
| 52 Week Range | 11.70 - 48.75 |
| Volume | |
| Avg. Volume | 445,342 |
| Market Cap | 390.663M |
| Beta (5Y Monthly) | 2.80 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Rock star Growth Puts Arcturus Therapeutics Holdings (NASDAQ:ARCT) In A Position To Use Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- Simply Wall St.
New Forecasts: Here's What Analysts Think The Future Holds For Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Shareholders in Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ) may be thrilled to learn that the analysts have...
- Zacks
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of 55.43% and 714.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
